@article{259dbe45c141426da7ce06df734f1edc,
title = "A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)",
keywords = "Nintedanib, Non-small cell lung cancer, Squamous, TRIPLE ANGIOKINASE INHIBITOR, CLINICAL-PRACTICE GUIDELINES, LABEL DOSE-ESCALATION, BIBF 1120, CONTROLLED-TRIAL, CARBOPLATIN, PACLITAXEL, BEVACIZUMAB, PHARMACOKINETICS, ANGIOGENESIS",
author = "Martin Forster and Allan Hackshaw and {De Pas}, Tommaso and Manuel Cobo and Pilar Garrido and Yvonne Summers and Dingemans, {Anne-Marie C.} and Michael Flynn and David Schnell and {von Wangenheim}, Ute and Arsene-Bienvenu Loembe and Rolf Kaiser and Lee, {Siow Ming}",
year = "2018",
month = jun,
day = "1",
doi = "10.1016/j.lungcan.2018.03.007",
language = "English",
volume = "120",
pages = "27--33",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
}